Yingli Wu

22PUBLICATIONS
47CO-AUTHORS
Molecular targetsMetabolic medicinePredictive and prognostic markersCancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 29, 2026
TRMT1-mediated tRNA m22G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma.

|Jun 10, 2026
The disulfonic acid ANDS disrupts ANP32B-p53 interaction to suppress chronic myeloid leukemia.

|Sep 24, 2025
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARĪ³.

Hao Luo, Chujiao Zhu, Yingying Wang

|Sep 11, 2025
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer.

Jun Lu, Minjuan Hu, Yikai Zhao

|Feb 22, 2024
Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma.

Xingming Zhang, Lou Geng, Yi Tang

|Jun 19, 2023
Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression.

Lin Qian, Na Li, Xiao-Chen Lu

Pageof 4

Frequent Collaborators

6 joint publications

Hu Lei

2 joint publications

Qun-Ying Lei

2 joint publications

Hua Yan

2 joint publications

Zheng-Jun Chen